Close Menu

NEW YORK – Meridan Bioscience announced Thursday it has submitted an assay for the detection of campylobacter species to the US Food and Drug Administration for 510(k) clearance.

The assay, called Curian Campy, detects campylobacter species C. jejuni, C. coli, C. upsaliensis, and C. lari in stool samples preserved in Cary-Blair-based transport media or unpreserved.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.